Laquinimod(CAS 248281-84-7)
UN No.:
UN 2811
| Purity | Grade | Package | Stock | Price | Quantity |
| 98% | RG | 250MG | In Stock | 66 USD
|
|
| 98% | RG | 1G | In Stock | 150 USD
|
|
| 98% | RG | 5G | In Stock | 586 USD
|
|
| 98% | RG | 25G | In Stock | 2552 USD
|
|
|
|||||
Your region is eligible for ordering. Available NMR Spectrum
Verified In Stock
Fast Shipping ISO 9001
Quality System
Promotion
Physical and chemical properties of 248281-84-7
Acidity coefficient |
4.50±1.00(Predicted) |
|---|---|
Boiling Point |
546.0±50.0 °C at 760 mmHg |
Density |
1.4±0.1 g/cm3 |
Flash Point |
284.0±30.1 °C |
Index of Refraction |
1.587 |
LogP |
2.79 |
Melting Point |
201 °C (decomp) |
Molecular Formula |
C19H17ClN2O3 |
Molecular Weight |
356.80 |
PSA |
87.42000 |
Solubility |
Soluble in DMSO (>25 mg/ml) |
Stability |
Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
Storage condition |
Sealed in dry,Room Temperature |
Vapour Pressure |
0.0±1.5 mmHg at 25°C |
Download COA of 248281-84-7
Spectrums of 248281-84-7
1.The NMR spectrum displayed on the page is a pre-sale reference spectrum and may differ from that of the actual received batch.
2.The accompanying documentation will include the NMR spectrum and purity analysis data for the shipped batch.
Download SDS of 248281-84-7
Pictograms |
  |
|---|---|
Signal Word |
Danger |
Hazard Statements |
H301 Toxic if swallowed H302+H332 Harmful if swallowed or if inhaled H302 Harmful if swallowed H332 Harmful if inhaled H341 Suspected of causing genetic defects H360 May damage fertility or the unborn child H362 May cause harm to breast-fed children |
Safety Data Sheet |
Q&A for CAS 248281-84-7
1. How can I verify product quality?
Every batch is tested in accordance with ISO 9001 requirements. We provide a Certificate of Analysis (COA), NMR spectrum, purity report, and test methods with each shipment. Third-party retesting is supported, and we offer a full refund if our data is incorrect.
2. What is the delivery time?
Orders are shipped on the second business day via FedEx, DHL, or UPS. International deliveries typically arrive within 7 business days (subject to customs clearance).
3. What if the received product doesn’t meet quality standards?
If the product does not match the COA or has a quality issue, we will issue a full refund or replacement upon verification.
4. Are hazardous labels included? How is safe shipping ensured?
Hazardous products are labeled and packaged in compliance with international regulations and shipped with an up-to-date Safety Data Sheet (SDS) to ensure safe and compliant transport.
5. Do you offer technical support?
Yes. Our technical team is available to assist with questions about product use, storage, purity requirements, applications, and more.
6. Are volume discounts available?
Yes. We offer competitive pricing for bulk orders. Please submit a quotation request, and we’ll provide a customized offer.
7. Do you provide samples?
Yes, samples are available for select products for testing and validation. Please submit a sample request or contact our sales team to confirm availability and specifications.
8. Do you have products in stock?
Items marked “In Stock” on our website are ready for immediate shipment, usually within 1–2 business days. Large packs or custom specifications require lead time confirmation.
9. Can you customize purity or packaging?
Yes. We support customization of purity, packaging size, and special testing requirements. Please share your detailed needs, and we’ll provide a solution.
10. Is the COA consistent with the shipped batch?
Yes. The COA provided with your shipment matches the actual batch and includes the batch number. COAs shown online are for reference or from previous batches.
11. Do you support long-term supply agreements?
Yes. We offer stable batch consistency, pricing agreements, and safety stock options for long-term customers to ensure uninterrupted supply.
12. What payment methods do you accept?
We accept bank transfer (T/T), PayPal, and other methods. Credit terms may be available for qualified long-term partners.
Applications of 248281-84-7
Laquinimod is primarily being investigated for its application in treating multiple sclerosis, particularly relapsing forms of the disease. Clinical trials have demonstrated its potential to reduce disease activity as measured by magnetic resonance imaging and to improve patient outcomes regarding relapse rates and disability progression. It has also shown promise in preclinical studies for other neurodegenerative conditions, although further research is needed to establish its efficacy across these applications.
Retrosynthesis analysis of 248281-84-7
Cas:103-69-5
Cas:335640-50-1
Cas:248282-10-2
Operate under the ISO 9001 system
